Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-16 3:50 pm Unchanged | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS | CAXTON CORP | 0 0% | 0 (Unchanged) | View |
2021-02-16 3:30 pm Purchase | 13G | CARDIFF ONCOLOGY INC CRDF | CAXTON CORP | 3,098,447 8.8% | 1,140,204 (+58.23%) | View |
2020-10-14 1:52 pm Purchase | 13G | REZOLUTE INC RZLT | CAXTON CORP | 564,243 6.6% | 564,243 (New Position) | View |
2020-10-01 5:55 pm Purchase | 13G | CTI BIOPHARMA CORP CTIC | CAXTON CORP | 4,487,317 6.1% | 4,487,317 (New Position) | View |
2020-09-23 10:37 am Purchase | 13D | STRONGBRIDGE BIOPHARMA PLC SHS SBBP | CAXTON CORP | 10,280,682 15.2% | 1,765,853 (+20.74%) | View |
2020-06-22 4:52 pm Purchase | 13G | CARDIFF ONCOLOGY INC CRDF | CAXTON CORP | 1,958,243 9.9% | 1,958,243 (New Position) | View |
2020-02-14 3:04 pm Purchase | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS | CAXTON CORP | 8,134,926 7.3% | 2,789,100 (+52.17%) | View |
2020-02-14 3:02 pm Purchase | 13G | ALCENTRA CAP CORP ABDC | CAXTON CORP | 1,005,000 7.8% | 238,000 (+31.03%) | View |
2020-02-14 2:59 pm Purchase | 13G | Garrison Capital Inc. GARS | CAXTON CORP | 1,223,096 7.6% | 5,374 (+0.44%) | View |
2020-02-14 2:57 pm Purchase | 13G | SCYNEXIS INC SCYX | CAXTON CORP | 7,936,111 8.2% | 3,611,111 (+83.49%) | View |
2020-02-14 1:46 pm Sale | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | CAXTON CORP | 659,252 3.8% | -211,568 (-24.30%) | View |
2020-02-14 1:29 pm Unchanged | 13G | INVESTCORP CR MGMT BDC INC ICMB | CAXTON CORP | 0 0% | 0 (Unchanged) | View |
2020-02-03 3:49 pm Purchase | 13G | SIERRA ONCOLOGY INC SRRA | CAXTON CORP | 1,082,200 9.9% | 1,082,200 (New Position) | View |
2019-10-21 12:51 pm Purchase | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | CAXTON CORP | 870,820 5.1% | 870,820 (New Position) | View |
2019-07-19 4:01 pm Purchase | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS | CAXTON CORP | 5,345,826 5.3% | 5,345,826 (New Position) | View |